Jamie L. Miller, Pharm.D., BCPS, BCPPS, FPPAG

Prof

Pharmacy Clinical & Admin Sci

Phone (405) 271-6878 x47296

Office COP300

Email jamie-miller@ou.edu


Publications & Presentations

<< 3 4 5 6 7 8 9 > >>
    26. Bradford C V, Parman A M, Johnson P N, Miller J L. Pharmacologic Management of Sialorrhea in Neonatal and Pediatric Patients. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 2024; 29 : 6-21

    27. Rathbun C, Lewis M M, Yuet W C, Woo S, Miller J L, Skrepnek G H. The Medication Possession Ratio as a Predictor of Longitudinal HIV-1 Viral Suppression. The Annals of pharmacotherapy. 2023; 57 : 1264-1272

    28. Spisany T, Siegrist E A, Miller J L, Neely S, White B P. Comparison of dosing strategies in obese patients prescribed intravenous acyclovir and evaluation of rate of acute kidney injury. International journal of antimicrobial agents. 2023; 62 : 106871

    29. Chang E, Johnson P N, Medina M, Dennis V C, Neely S, Miller J L. Sculpting a teaching and learning curriculum to better meet the career needs of postgraduate year 1 and 2 pharmacy residents. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2023; 80 : 765-771

    30. Bradford C V, Miller J L, Ranallo C D, Neely S, Johnson P N. Vasopressin-Induced Hyponatremia in Infants Following Cardiovascular Surgery. The Annals of pharmacotherapy. 2023; 57 : 259-266

<< 3 4 5 6 7 8 9 > >>



Grants

1 2 >>
    1. Selenium Pharmacokinetics and Pharmacodynamics of Infants with Intestinal Failure a Prospective Cohort Study. Misc Non-Federal. Start Date: 2025. End Date: 2026.

    2. Evaluation of caffeine dosing regimens and the impact of developmental pharmacokinetics in neonates with apnea of prematurity. Misc Non-Federal. Start Date: 2020. End Date: 2021.

    3. Characterization of fentanyl metabolic and renal elimination pathways in children less than two years of age. Misc Non-Federal. Start Date: 2018. End Date: 2020.

    4. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.

    5. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.

1 2 >>



Awards and Honors

1 2 3 4 >>
                                                                                            1. Pediatric Pharmacy Association. Outstanding Original Research Award. Date: 2026.  

                                                                                            2. University of Oklahoma College of Pharmacy Alumni Association. Ralph D. Bienfang Outstanding Practitioner Award. Date: 2025.  

                                                                                            3. Oklahoma Residency Research Conference. Oklahoma Research Excellence Award (Mentor). Date: 2025.  

                                                                                            4. Oklahoma Residency Research Conference. Oklahoma Research Excellence Award (Mentor). Date: 2024.  

                                                                                            5. Oklahoma Residency Research Conference. Oklahoma Research Excellence Award (Mentor). Date: 2024.  

1 2 3 4 >>



Education

                                                                                            1.  Degree: PharmD. Southwestern Oklahoma State University. Date: 2006.  

                                                                                            2.  Degree: BS. Trevecca Nazarene University. Date: 2002.  




Administrative Assignments

                                                

    1. Role: Department Vice-Chair. Scope: Department. Date: 2021.